Patócs Attila
Örökletes Daganatok Kutatócsoport, MTA-SE, Budapest, Hungary.
Magy Onkol. 2020 Mar 17;64(1):25-31. Epub 2020 Feb 2.
The technical developments lead to revolution and speed-up of molecular genetic diagnostics of hereditary cancer syndromes. In those apparently sporadic, solid tumors where the chance of inheritance is higher than 10%, the molecular genetic analysis is indicated. Nowadays these tests are performed using next generation sequencing technologies which allow parallel testing of multiple genes. However, in well-defined cancer syndromes where the clinical presentation clearly suggests the diagnosis and the disease is monogenic, targeted testing is still recommended. Clinical indication of molecular genetic testing and its interpretation is a complex procedure; all steps are regulated. Beside ethical and legal aspects both the laboratory, bioinformatic steps and the interpretation of the results require strong supervision and control. The current review summarizes the genetic alterations responsible for hereditary cancer syndromes and molecular genetic methods which are used during diagnostics in everyday practice.
技术发展推动了遗传性癌症综合征分子遗传学诊断的变革与加速。在那些明显为散发性实体瘤且遗传几率高于10%的病例中,建议进行分子遗传学分析。如今,这些检测使用下一代测序技术进行,该技术可对多个基因进行平行检测。然而,在临床表现明确提示诊断且疾病为单基因的明确癌症综合征中,仍推荐进行靶向检测。分子遗传学检测的临床指征及其解读是一个复杂的过程;所有步骤都受到规范。除了伦理和法律方面,实验室、生物信息学步骤以及结果解读都需要严格的监督和控制。本综述总结了导致遗传性癌症综合征的基因改变以及日常诊断中使用的分子遗传学方法。